What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.17%Below 5Y avg (4.28%)
Annual Rate
KRW 2000.00Paid semi-annual
Payout Ratio
23.8%Sustainable
Last Ex-Dividend
Aug 6, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
21.07TKRW
15.18B · vs all stocks (USD)
Updated Aug 20, 2026
Trailing P/E
278.49x
vs Conglomerates peers
Updated Aug 20, 2026
Revenue (TTM)
20.55TKRW
14.80B · vs all stocks (USD)
Updated Aug 20, 2026
Profit Margin
0.44%
vs Conglomerates peers
Updated Aug 20, 2026
Beta
2.04x
vs all stocks
Updated Aug 20, 2026
52-Week Change
118.15%
vs all stocks
Updated Aug 20, 2026
Forward Annual Dividend Yield
0.17%
vs all stocks
Updated Aug 20, 2026
Market Capitalization
21.07TKRW
15.18B · vs all stocks (USD)
Updated Aug 20, 2026
Enterprise Value
37.53TKRW
27.05B · vs all stocks (USD)
Updated Aug 20, 2026
Trailing P/E
278.49x
vs Conglomerates peers
Updated Aug 20, 2026
Forward P/E
26.09x
vs Conglomerates peers
Updated Aug 20, 2026
PEG Ratio
4.28x
vs Conglomerates peers
Updated Aug 20, 2026
Price to Sales (TTM)
1.03x
vs Conglomerates peers
Updated Aug 20, 2026
Price to Book (MRQ)
1.20x
vs Conglomerates peers
Updated Aug 20, 2026
Enterprise to Revenue
1.83x
vs Conglomerates peers
Updated Aug 20, 2026
Enterprise to EBITDA
19.05x
vs Conglomerates peers
Updated Aug 20, 2026
Gross Margin
18.67%
vs Conglomerates peers
Updated Aug 20, 2026
Profit Margin
0.44%
vs Conglomerates peers
Updated Aug 20, 2026
Operating Margin
6.72%
vs Conglomerates peers
Updated Aug 20, 2026
Return on Assets (TTM)
2.19%
vs Conglomerates peers
Updated Aug 20, 2026
Return on Equity (TTM)
2.69%
vs Conglomerates peers
Updated Aug 20, 2026
Revenue (TTM)
20.55TKRW
14.80B · vs all stocks (USD)
Updated Aug 20, 2026
Revenue per Share (TTM)
1.21MKRWUpdated Aug 20, 2026
Quarterly Revenue Growth
17.70%
vs Conglomerates peers
Updated Aug 20, 2026
Gross Profit (TTM)
3.63TKRW
2.62B · vs all stocks (USD)
Updated Aug 20, 2026
EBITDA (TTM)
1.95TKRW
1.41B · vs all stocks (USD)
Updated Aug 20, 2026
Net Income (TTM)
59.32BKRW
42.74M · vs all stocks (USD)
Updated Aug 20, 2026
Quarterly Earnings Growth (YoY)
65.40%
vs Conglomerates peers
Updated Aug 20, 2026
Operating Cash Flow (TTM)
1.11TKRW
802.64M · vs all stocks (USD)
Updated Aug 20, 2026
Levered Free Cash Flow (TTM)
660.20BKRW
475.71M · vs all stocks (USD)
Updated Aug 20, 2026
Forward Annual Dividend Rate
2.00KKRWUpdated Aug 20, 2026
Forward Annual Dividend Yield
0.17%
vs all stocks
Updated Aug 20, 2026
Trailing Annual Dividend Rate
2.00KKRWUpdated Aug 20, 2026
Trailing Annual Dividend Yield
0.17%
vs all stocks
Updated Aug 20, 2026
5-Year Average Dividend Yield
4.28%
vs all stocks
Updated Aug 20, 2026
Payout Ratio
23.75%
vs Conglomerates peers
Provider-reported. Trailing Annual Dividend Rate ÷ Diluted EPS (TTM) on this page gives 47.69%.Updated Aug 20, 2026
Minority Interest (Equity)
10.68TKRWFY2025 · Dec 31, 2025
Revenue
19.78TKRWFY2025 · Dec 31, 2025
Cost of Goods Sold
16.37TKRWFY2025 · Dec 31, 2025
Gross Profit
3.41TKRWFY2025 · Dec 31, 2025
Operating Income
1.06TKRW
765.77M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
490.17BKRWFY2025 · Dec 31, 2025
Income Tax Expense
240.66BKRWFY2025 · Dec 31, 2025
Net Income
249.51BKRWFY2025 · Dec 31, 2025
EBIT
987.39BKRWFY2025 · Dec 31, 2025
EBITDA (Income Statement)
1.77TKRWFY2025 · Dec 31, 2025
Research & Development
313.53BKRWFY2025 · Dec 31, 2025
Selling, General & Administrative
615.90BKRWFY2025 · Dec 31, 2025
Other Operating Expenses
73.98BKRWFY2025 · Dec 31, 2025
Non-operating Interest Income
119.56BKRWFY2025 · Dec 31, 2025
Non-operating Interest Expense
497.23BKRWFY2025 · Dec 31, 2025
EPS (Basic)
4.23KKRWFY2025 · Dec 31, 2025
EPS (Diluted)
4.19KKRWFY2025 · Dec 31, 2025
Net Income from Continuing Operations
249.51BKRWFY2025 · Dec 31, 2025
Minority Interests (P&L)
-173.73BKRWFY2025 · Dec 31, 2025
Operating Cash Flow
-300.35BKRWFY2025 · Dec 31, 2025
Free Cash Flow
-846.83BKRWFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
4.93TKRWFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
249.51BKRWFY2025 · Dec 31, 2025
Stock-based Compensation
135.38BKRWFY2025 · Dec 31, 2025
Other Non-cash Items
358.39BKRWFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-833.25BKRWFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-210.38BKRWFY2025 · Dec 31, 2025
Capital Expenditures
-546.48BKRWFY2025 · Dec 31, 2025
Net Intangibles (CF)
-326.25BKRWFY2025 · Dec 31, 2025
Net Acquisitions
365.63BKRWFY2025 · Dec 31, 2025
Purchase of Investments
-370.13BKRWFY2025 · Dec 31, 2025
Sale of Investments
340.02BKRWFY2025 · Dec 31, 2025
Other Investing Activity
52.98BKRWFY2025 · Dec 31, 2025
Net Investing Cash Flow
-157.99BKRWFY2025 · Dec 31, 2025
Long-term Debt Issuance
1.26TKRWFY2025 · Dec 31, 2025
Long-term Debt Payments
-1.17TKRWFY2025 · Dec 31, 2025
Net Short-term Debt Issuance
925.62BKRWFY2025 · Dec 31, 2025
Common Stock Repurchase
-138.66BKRWFY2025 · Dec 31, 2025
Common Dividends Paid
-147.03BKRWFY2025 · Dec 31, 2025
Other Financing Charges
148.13BKRWFY2025 · Dec 31, 2025
Net Financing Cash Flow
876.62BKRWFY2025 · Dec 31, 2025
Shares Outstanding
13.60MSharesUpdated Aug 20, 2026
Float Shares
10.67MSharesUpdated Aug 20, 2026
% Held by Insiders
41.24%
vs all stocks
Updated Aug 20, 2026
% Held by Institutions
22.13%
vs all stocks
Updated Aug 20, 2026
Total Cash (MRQ)
5.50TKRW
3.96B · vs all stocks (USD)
Updated Aug 20, 2026
Total Cash per Share (MRQ)
307.68KKRWUpdated Aug 20, 2026
Total Debt (MRQ)
10.59TKRW
7.63B · vs all stocks (USD)
Updated Aug 20, 2026
Total Debt to Equity (MRQ)
0.7954x
vs Conglomerates peers
Updated Aug 20, 2026
Current Ratio (MRQ)
1.03x
vs Conglomerates peers
Updated Aug 20, 2026
Book Value per Share (MRQ)
980.73KKRWUpdated Aug 20, 2026
Total Assets
32.93TKRW
23.73B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
14.19TKRWFY2025 · Dec 31, 2025
Total Liabilities
20.69TKRWFY2025 · Dec 31, 2025
Total Non-current Assets
18.73TKRWFY2025 · Dec 31, 2025
Total Non-current Liabilities
6.94TKRWFY2025 · Dec 31, 2025
Total Current Liabilities
13.75TKRWFY2025 · Dec 31, 2025
Cash Equivalents
4.93TKRWFY2025 · Dec 31, 2025
Cash & Cash Equivalents
4.93TKRWFY2025 · Dec 31, 2025
Other Short-term Investments
175.67BKRWFY2025 · Dec 31, 2025
Accounts Receivable
4.01TKRWFY2025 · Dec 31, 2025
Inventory
3.01TKRWFY2025 · Dec 31, 2025
Accounts Payable
5.15TKRWFY2025 · Dec 31, 2025
Short-term Debt
5.76TKRWFY2025 · Dec 31, 2025
Other Current Liabilities
850.27BKRWFY2025 · Dec 31, 2025
Long-term Debt
4.37TKRWFY2025 · Dec 31, 2025
Other Non-current Liabilities
405.51BKRWFY2025 · Dec 31, 2025
Common Stock (Book)
99.29BKRWFY2025 · Dec 31, 2025
Retained Earnings
-80.64BKRWFY2025 · Dec 31, 2025
Total Shareholders' Equity
12.23TKRW
8.82B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
162.48BKRWFY2025 · Dec 31, 2025
52-Week Low
507.00KKRWUpdated Aug 20, 2026
52-Week High
2.49MKRWUpdated Aug 20, 2026
52-Week Change
118.15%
vs all stocks
Updated Aug 20, 2026
Beta
2.04x
vs all stocks
Updated Aug 20, 2026
50-Day MA
1.35MKRWUpdated Aug 20, 2026
200-Day MA
1.18MKRWUpdated Aug 20, 2026
Avg 10-Day Volume
48.37KSharesUpdated Aug 20, 2026
Avg 30-Day Volume
76.71KSharesUpdated Aug 20, 2026
Diluted EPS (TTM)
4.19KKRWUpdated Aug 20, 2026
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
P/E ratio is 278.49×, higher than 95% of its Conglomerates peers (median 25.54×)Significant